Related Experiment Video
Updated: May 20, 2026

Human Ex vivo Wound Model and Whole-Mount Staining Approach to Accurately Evaluate Skin Repair
Published on: February 17, 2021
Cyclooxygenase-2 inhibitors modulate skin aging in a catalytic activity-independent manner
Mi Eun Lee1, So Ra Kim, Seungkoo Lee
1Department of Biochemistry and Molecular Biology, Institute of Medical Sciences, Kangwon National University School of Medicine, Chuncheon 200-701, Korea.
Abstract:
It has been proposed that the pro-inflammatory catalytic activity of cyclooxygenase-2 (COX-2) plays a key role in the aging process. However, it remains unclear whether the COX-2 activity is a causal factor for aging and whether COX-2 inhibitors could prevent aging. We here examined the effect of COX-2 inhibitors on aging in the intrinsic skin aging model of hairless mice. We observed that among two selective COX-2 inhibitors and one non-selective COX inhibitor studied, only NS-398 inhibited skin aging, while celecoxib and aspirin accelerated skin aging. In addition, NS-398 reduced the expression of p53 and p16, whereas celecoxib and aspirin enhanced their expression. We also found that the aging-modulating effect of the inhibitors is closely associated with the expression of type I procollagen and caveolin-1. These results suggest that pro-inflammatory catalytic activity of COX-2 is not a causal factor for aging at least in skin and that COX-2 inhibitors might modulate skin aging by regulating the expression of type I procollagen and caveolin-1.
Insights
Cyclooxygenase-2 (COX-2) inhibitors
Area of Science:
- Biochemistry
- Dermatology
- Gerontology
Background:
- The pro-inflammatory activity of cyclooxygenase-2 (COX-2) is implicated in aging.
- Its causal role in aging and the potential of COX-2 inhibitors to prevent aging remain undetermined.
Purpose of the Study:
- To investigate the effects of COX-2 inhibitors on skin aging using a hairless mouse model.
- To determine if COX-2 activity is a causal factor in skin aging.
Main Methods:
- Utilized a hairless mouse model for intrinsic skin aging.
- Administered selective COX-2 inhibitors (NS-398, celecoxib) and a non-selective COX inhibitor (aspirin).
- Assessed skin aging markers, including p53, p16, type I procollagen, and caveolin-1 expression.
Main Results:
- Only NS-398 inhibited skin aging; celecoxib and aspirin accelerated it.
- NS-398 decreased p53 and p16 expression, while celecoxib and aspirin increased them.
- Inhibitor effects correlated with changes in type I procollagen and caveolin-1 expression.
Conclusions:
- Pro-inflammatory COX-2 activity is not a direct cause of skin aging.
- COX-2 inhibitors can modulate skin aging, potentially by regulating type I procollagen and caveolin-1.
- Different COX-2 inhibitors have distinct effects on skin aging processes.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Effect of Aging on Tissues
Radical Autoxidation
Renewal of Skin Epidermal Stem Cells